The Asia Pacificbreast cancer screening market was valued at US$ 798.57 million in 2019 and is projected to reach US$ 1,120.77 million by 2027; it is expected to grow at a CAGR of 5.4% from 2020 to 2027.
As per the Centers for Disease Control and Prevention (CDC) definition, breast cancer screening refers tochecking a woman’s breasts for cancer before there are signs or symptoms of the disease. The purpose of screening tests is to discover cancer at an early stage when it can be operated or cured. At times, a screening test detects cancer when it is very small or growingslowly.
India Breast Cancer Screening Market Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Investmentsfor Research in Breast Cancer Management
Increasing research activities is likely to enhance the breast cancer screening market in Asia Pacific. For instance, “Novel combination of serum microRNA for detecting breast cancer in the early stage” was conducted in Japan. Furthermore, the government in Japan has initiated cancer control programs as it is one of the leading cause of death in Japan. Cancer screening programs are carried out throughout the country by the municipalities with the government support.
Additionally, increasing research for early diagnosis of breast cancer is likely to favor the breast cancer screening market in Australia. For instance, in October 2019, a NBCF funded (national breast cancer foundation) researcher Sydney University published theresults of pilot trial of 3D mammography (known as tomosynthesis), as per thestudy, breast cancer detection rates are higher with 3D mammography as compared withthe standard 2D mammography.
Test Type-Based Market Insights
Based on test type,the breast cancer screeningmarket is segmented into imaging test, Immunohistochemistry test, genetic test, and blood marker tests. In 2019,the imaging testsegment held the largest share of the market in 2019; moreoverit is anticipated to register the highest CAGR in the market during the forecast period.
Asia Pacific Breast Cancer Screening Market, by Test Type– 2019and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End User-Based MarketInsights
Based onend user, the breast cancer screeningmarketis further segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019; moreoverit is estimated to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Asia Pacific Breast Cancer Screening Market: Strategic Insights
Market Size Value in US$ 798.57 Million in 2019 Market Size Value by US$ 1,120.77 Million by 2027 Growth rate CAGR of 5.4% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Asia Pacific Breast Cancer Screening Market: Strategic Insights
| Market Size Value in | US$ 798.57 Million in 2019 |
| Market Size Value by | US$ 1,120.77 Million by 2027 |
| Growth rate | CAGR of 5.4% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches and approvalsarethe commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the breast cancer screeningmarketadopt the expansion, collaboration, and product launch strategies to enlarge customer base acrossthe world.These strategies allow the players to maintain their brand name globally. For instance, in October 2018, GE Healthcare launched a product, namely, the Invenia Automated Breast Ultrasound (ABUS) 2.0 in the US. The device is FDA-approved ultrasound supplemental breast screening technology, specifically designed for detecting cancer in dense breast tissue.
By Test Type
- Blood Marker Test
- Imaging Test
- Genetic Test
- Immunohistochemistry Test
By End User
- Diagnostic Centres
- Hospitals
- Research Laboratories
- Cancer Institutes
By Country
- China
- Japan
- India
- Australia
- South Korea
Company Profiles
- Koninklijke Philips N.V.
- Hologic, Inc.
- Becton, Dickinson and Company
- Myriad Genetics, Inc.
- Siemens Healthcare AG
- Exact Sciences Corporation
- OncoCyte Corporation
- POC Medical Systems
- DanaherCorporation
- General Electric Company
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test Type,End User, and Country.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Breast Cancer Screening Market – By Test Type
1.3.2 Asia Pacific Breast Cancer Screening Market – By End User
1.3.3 Asia Pacific Breast Cancer Screening Market– By Region
2. Breast Cancer Screening Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Breast Cancer Screening – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific
4.3 Expert Opinion
5. Asia Pacific Breast Cancer Screening Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing Investments For Research in Breast Cancer Management
5.1.2 Growing Breast Cancer Prevalence Across Asia Pacific
5.2 Key Market Restraints
5.2.1 High Cost Associated With Breast Cancer Screening
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Agreements And Collaborations For Diagnostic Solutions
5.5 Impact Analysis
6. Breast Cancer Screening Market – Regional Analysis
6.1 Asia Pacific Breast Cancer Screening Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players
7. Breast Cancer Screening Market Analysis – By Test Type
7.1 Overview
7.2 Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)
7.2.1 Asia Pacific Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
7.3 Blood Marker Test
7.3.1 Overview
7.4 Blood Marker Tests: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Imaging Test
7.5.1 Overview
7.5.2 Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
7.6 Genetic Test
7.6.1 Overview
7.6.2 Genetic Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Immunohistochemistry Test
7.7.1 Overview
7.7.2 Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8. Breast Cancer Screening Market – By End User
8.1 Overview
8.2 Breast Cancer Screening Market, by End User, 2019 and 2027 (%)
8.2.1 Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostics Centers
8.4.1 Overview
8.4.2 Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Research Laboratories
8.5.1 Overview
8.6 Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Cancer Institutes
8.7.1 Overview
8.8 Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
9. Breast Cancer Screening Market– Regional Analysis
9.1 Asia Pacific: Breast Cancer Screening Market
9.1.1 Overview
9.1.2 Asia Pacific: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.4 Asia Pacific: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.5 Asia Pacific: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
9.1.6 China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 China: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.6.3 China: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.7 Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Japan: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.7.3 Japan: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.8 India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 India: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.8.3 India: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.9 South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 South Korea: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.9.3 South Korea: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.10 Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Australia: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.10.3 Australia: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic On Asia Pacific Breast Cancer Screening Market
10.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11. Breast Cancer Screening Market – Key Company Profiles
11.1 General Electric Company
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Siemens Healthineers AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Koninklijke Philips N.V.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Hologic, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 BD
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Myriad Genetics, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Danaher
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. China Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 6. China Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Japan Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. IndiaBreast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 10. IndiaBreast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. South Korea Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 12. South Korea Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Australia Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Australia Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 15. Glossary of Terms, Breast Cancer Screening Market
LIST OF FIGURES
Figure 1. Breast Cancer Screening Market Segmentation
Figure 2. Breast Cancer Screening Segmentation – By Region
Figure 3. Asia Pacific Breast Cancer Screening Market Overview
Figure 4. The Imaging Test Segment Held Largest Share Of Test Type Segment In Breast Cancer Screening Market
Figure 5. India Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific PEST Analysis
Figure 7. Breast Cancer Screening Market Impact Analysis Of Driver And Restraints
Figure 8. Asia Pacific Breast Cancer Screening Market – Revenue Forecast And Analysis – 2019- 2027
Figure 9. Market Positioning Of Key Players In Breast Cancer Screening Market
Figure 10. Breast Cancer Screening Market Revenue Share, by Test Type, 2019 and 2027 (%)
Figure 11. Blood Marker Tests: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 12. Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Genetic Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Breast Cancer Screening Market, by End User, 2019 and 2027 (%)
Figure 16. Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Asia Pacific: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)
Figure 21. Asia Pacific Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
Figure 22. China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
The List of Companies - Asia Pacific Breast Cancer Screening Market
- Koninklijke Philips N.V.
- Hologic, Inc.
- Becton, Dickinson and Company
- Myriad Genetics, Inc.
- Siemens Healthcare AG
- Exact Sciences Corporation
- OncoCyte Corporation
- POC Medical Systems
- DanaherCorporation
- General Electric Company
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Breast Cancer Screening Market
Jun 2020
Therapeutic Vaccines Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Cancer Vaccines, Infectious Disease Vaccines, and Others), Technology (Allogenic Vaccines and Autologous Vaccines), End User (Hospitals, Clinics, and Others), and Geography
Jun 2020
Medical Cables Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Medical Cables, Reusable Medical Cables, and Custom Medical Cables), Applications [Diagnostics (Ultrasound Cables, Endoscopy Cables, Patient Interface Cables, and Others), Motorized Equipment, Patient Monitoring (ECG Cables, SpO2 Cables, NiBP Cables, EEG Cables, and Others), Surgical and Life Support (Fiber Optics, Modular Local Area Network, and Others), and Others], End User (Hospital and Clinics, Diagnostic Laboratories and Imaging Centers, Ambulatory Surgical Centers, and Others), and Geography
Jun 2020
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Jun 2020
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Jun 2020
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Jun 2020
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Jun 2020
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Jun 2020
Infusion Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Infusion Pumps Pumps [Volumetric Pumps, Syringe Pumps, Insulin Pumps, Patient Control Analgesia (PCA) Pumps, Enteral Pumps, Implantable Pumps, and Elastomeric Pumps] and Infusion Sets [Vented Infusion Sets and Non-Vented Infusion Sets], Application (Diabetes, Oncology, Pain Management, Hematology, Pediatrics, Gastroenterology, and Others), End User (Hospitals and Specialty Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others), and Geography
Get Free Sample For